Jin Medical (ZJYL) announced that it received a deficiency letter from the Nasdaq. The notice informed the company that, based upon the closing bid price of the company’s ordinary shares over the 30 consecutive business day period between March 20 and May 1 the company is not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its ordinary shares for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZJYL: